The ACQUITY Premier Oligonucleotide BEH C18 Column, 300 Å, 1.7 µm, 2.1 x 50 mm, is used to separate oligonucleotides via ion-pairing reversed-phase (IP-RP) chromatography on UPLC systems. Each column incorporates Waters' BEH hybrid particle technology for unmatched pH and temperature stability and our MaxPeak Premier high performance surface technology for ultra-low non-specific adsorption. Stationary phase batches are also QC tested using the Waters MassPREP Oligonucleotide Standard to ensure lot-to-lot performance. Premier Oligonucleotide BEH Columns provide unmatched sensitivity, exquisite reproducibility, and excellent out-of-the-box performance. Columns with 130Å pore size particles deliver industry leading performance for short-mer oligonucleotide separations, and new 300Å pore size columns offer enhanced resolution for longer oligonucleotides.
Waters is phasing out Certificate of Analysis (COAs) for eCords. All column documents are now available at www.waters.com/coa
|
Chemistry |
C18 |
|
Separation Mode |
Reversed Phase |
|
Particle Substrate |
Hybrid |
|
pH Range Min |
1 pH |
|
pH Range Max |
12 pH |
|
Maximum Pressure |
18000 psi (1240 Bar) |
|
Endcapped |
Yes |
|
Silanol Activity |
Low |
|
Particle Shape |
Spherical |
|
Particle Size |
1.7 µm |
|
Endfitting Type |
Parker-style |
|
Pore Size |
300 Å |
|
QC Tested |
Oligonucleotide |
|
Format |
Column |
|
System |
UPLC |
|
Particle Technology |
BEH |
|
Technique |
LC |
|
USP Classification |
L1 |
|
Inner Diameter |
2.1 mm |
|
Length |
50 mm |
|
Carbon Load |
18 % |
|
eCord |
Yes |
|
UNSPSC |
41115711 |
|
Application |
Oligonucleotide, Gene Therapeutics |
|
Brand |
ACQUITY |
|
Product Type |
Columns |
|
Units per Package |
1 pk |